SCHEMBL11899248

SCHEMBL11899248

O=C(c1ccccc1)c1ccc2c(c1)c1cccc3c1n2-c1ccccc1C3(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 1/20 0.41
▸ ATM Q13315 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ ALDH1A1 P00352 5/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ GLA P06280 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.36
▸ HPGD P15428 3/20 0.35
▸ PDK2 Q15119 1/20 0.35
▸ PBRM1 Q86U86 1/20 0.35
▸ TP53 P04637 1/20 0.34
▸ MAPT P10636 2/20 0.34
▸ PTGS1 P23219 2/20 0.34
▸ CXCR1 P25024 2/20 0.34
▸ CXCR2 P25025 2/20 0.34
▸ PTGS2 P35354 2/20 0.34
▸ RECQL P46063 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11926654 0.98 CNR2 (0.38) CNR2ATMTDP1L3MBTL1ALDH1A1
SCHEMBL11926671 0.94 CNR2 (0.37) CNR2ATMTDP1L3MBTL1ALDH1A1
SCHEMBL11926656 0.91 CNR2 (0.39) CNR2ATML3MBTL1ALDH1A1KDM4E
SCHEMBL11926751 0.91 CNR2 (0.39) CNR2ATMTDP1L3MBTL1ALDH1A1
SCHEMBL11926659 0.88 PDK2 (0.37) CNR2ALDH1A1SMN1; SMN2GLAKDM4E
SCHEMBL11926604 0.86 CNR2 (0.46) CNR2ATMTDP1L3MBTL1ALDH1A1
SCHEMBL11926754 0.85 POLB (0.35) CNR2ATMALDH1A1SMN1; SMN2GLA
SCHEMBL11926652 0.83 POLB (0.35) CNR2ATMTDP1L3MBTL1ALDH1A1
SCHEMBL11901193 0.82 CNR2 (0.40) CNR2ATMTDP1L3MBTL1ALDH1A1
SCHEMBL12521380 0.81 KDM4E (0.31) KDM4EMAPTMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785636-B2 Substituted indoloacridines for organic electroluminescent devices MERCK PATENT GMBH (DE) 2014-07-22 — — US disclosed
US-8785636-B2 Substituted indoloacridines for organic electroluminescent devices MERCK PATENT GMBH (DE) 2014-07-22 — — US disclosed
US-20120202997-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-08-09 — — US disclosed
US-20120202997-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-08-09 — — US disclosed
US-20120202997-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2012-08-09 — — US disclosed
WO-2011042107-A2 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2011-04-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202997-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES EPCAM, L1CAM, OR10J3 CNR2 3281/4885ATM 3650/4885TDP1 2475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback